Table 2.
Characterization of the pooled STRAWINSKI and PREDICT population.
| Variable | All patients (n = 450) | Good outcome (mRS ⩽ 2) (n = 195) | Poor outcome (mRS ⩾ 3) (n = 255) |
|---|---|---|---|
| Demographics | |||
| Age (years) | 73 (66–81) | 69 (61–76) | 78 (70–84) |
| Male sex | 242 (54) | 122 (63) | 120 (47) |
| NIHSS | 8 (3–14) | 4 (2–6) | 13 (8–17) |
| Etiology | |||
| Large artery atherosclerosis | 137 (31) | 72 (37) | 65 (26) |
| Cardioembolism | 165 (37) | 48 (24) | 117 (46) |
| Small artery occlusion | 40 (9) | 28 (14) | 12 (5) |
| Other determined cause | 15 (3) | 7 (4) | 8 (3) |
| Undetermined etiology | 91 (20) | 40 (21) | 51 (20) |
| Risk factors | |||
| Atrial fibrillation | 161 (36) | 43 (23) | 118 (46) |
| Hypertension | 376 (84) | 154 (79) | 222 (87) |
| Diabetes mellitus | 119 (27) | 37 (19) | 82 (32) |
| Hyperlipidemia | 234 (52) | 103 (53) | 131 (52) |
| Previous stroke | 90 (20) | 34 (18) | 56 (22) |
| Biomarkers | |||
| MR-proANP (pmol/L) | 156 (90–257) | 114 (71–174) | 206 (116–321) |
| Procalcitonin (μg/L) | 0.034 (0.023–0.052) | 0.030 (0.022–0.044) | 0.038 (0.023–0.066) |
| Copeptin (pmol/L) | 10.5 (6.1–26.1) | 7.3 (5.0–13.7) | 17.8 (7.8–35.8) |
mRS: modified Rankin scale; NIHSS: National Institutes of Health Stroke Scale; MR-proANP: midregional proatrial natriuretic peptide.
Data are median (quartiles) or n (percent).